Effect of Sevoflurane, Propofol and Dexmedetomidine on Delirium & Neuroinflammation in Mechanically Ventilated Patients
NCT ID: NCT02394418
Last Updated: 2019-08-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
PHASE4
INTERVENTIONAL
2017-09-01
2018-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Inhalation Sedation Compared With Propofol on the Sepsis-related Acute Respiratory Distress Syndrome Course
NCT04014218
Sevoflurane Decreases the Risk of Postoperative Delirium After Cerebral Hypoxemia During Surgery
NCT02133638
The Effect of Desflurane Versus Sevoflurane on Postoperative Recovery
NCT05331027
Post Extubation Delirium and End-tidal Sevoflurane Concentration
NCT02489734
Sevoflurane/Dexmedetomidine vs. Isoflurane for Pediatric Emergence Delirium
NCT06624592
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sevoflurane
Treatment of delirium by inhaled sevoflurane
Sevoflurane
Treatment of delirium by inhaled sevoflurane
Propofol
Treatment of delirium by propofol i.v. infusion
Propofol
Treatment of delirium by propofol i.v. infusion
Dexmedetomidine
Treatment of delirium by dexmedetomidine i.v. infusion
Dexmedetomidine
Treatment of delirium by dexmedetomidine i.v. infusion
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sevoflurane
Treatment of delirium by inhaled sevoflurane
Propofol
Treatment of delirium by propofol i.v. infusion
Dexmedetomidine
Treatment of delirium by dexmedetomidine i.v. infusion
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* any mental disorder
* presence of cancer
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Moscow Regional Research and Clinical Institute (MONIKI)
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Valery V. Likhvantsev, Professor
senior researcher
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Valery Likhvantsev, MD,PhD
Role: PRINCIPAL_INVESTIGATOR
Moscow Regional Research Clinical Institute
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
S-D-P-MV-220115
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.